Related Experiment Video
Updated: May 24, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Immunosuppressive treatment in primary focal segmental glomerulosclerosis
Shizhang Xu1, Gaosi Xu, Lei Zeng
1Department of Nephrology, Second Affiliated Hospital, Nanchang University, Nanchang, PR China.
Background:
The therapeutic effects of immunosuppressive agents such as cyclosporin A, mycophenolate mofetil, rituximab and sirolimus on primary focal segmental glomerulosclerosis (FSGS) remain controversial. The present study was intended to review and analyze the treatment results of immunosuppressive agents for primary FSGS in child and adult patients.
Methods:
Complete remission rates and partial remission rates were extracted from published articles and analyzed using statistical tests.
Results:
Cyclosporin A was effective in the treatment of child and adult patients with idiopathic FSGS. Rituximab therapy displayed a higher complete remission and partial remission rate in children than in adult FSGS patients.
Conclusions:
Multiple-center large-scale rigorous trials should be considered to evaluate the risk-benefit ratio of immunosuppressive treatment in patients with primary FSGS.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant II: Surgical Procedure
